I said less than one percent based on the below info. 34 approved hospitals divided the number of hospitals in the UK (1,121) gave me a take up rate of less than 1%. But please DYOR that number below could be wrong as it says it depends on your definition. Its all I could find in regards to hospital numbers. If anyone else could provide a more definite figure it would be appreciated.
![]()
The below is taken from MVP European Update dated August 12, 2016
In the United Kingdom, Penthrox was launched in February 2016 and in the Republic of Ireland in April 2016. Since that time, MVP’s marketing partner Galen Limited has worked closely with major hospitals in the preparation and submission of more than 130 Hospital Formulary Applications. The hospitals targeted in the first phase of formulary applications cover a significant percentage of the emergency cases seen in the UK and Ireland.
Galen Managing Director Mr. David Bennett said: “Formulary applications take circa 6 months before a new product is listed for use. So far, we have achieved 11 formulary listings and we have confirmed hospital drug and therapeutic committee dates for a further 21. Our roll out of Penthrox is going to plan and we are very confident of acceptance in the Emergency Departments
I was expecting that after Galen submitted 130 applications in April 2016 we would have more than 34 approved hospitals in the UK by Feb 17. I realise the approvals take time and no doubt that number will swell in the near future. That's enough from me I will go back and put my rose coloured glasses back on.![]()
- Forums
- ASX - By Stock
- Ann: Penthrox European Update
I said less than one percent based on the below info. 34...
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MVP (ASX) to my watchlist
|
|||||
Last
45.5¢ |
Change
-0.015(3.19%) |
Mkt cap ! $47.52M |
Open | High | Low | Value | Volume |
46.5¢ | 47.5¢ | 45.5¢ | $98.40K | 210.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12936 | 45.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 649 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12936 | 0.455 |
2 | 75000 | 0.450 |
1 | 1459 | 0.445 |
1 | 163 | 0.430 |
2 | 29735 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 649 | 1 |
0.490 | 289 | 1 |
0.500 | 7433 | 4 |
0.510 | 1000 | 1 |
0.520 | 90 | 1 |
Last trade - 15.47pm 15/08/2024 (20 minute delay) ? |
Featured News
MVP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online